Bausch & Lomb Corp cash flow statement
In fiscal 2025, Bausch & Lomb Corp's operations generated $283m of cash; it spent $349m on capital projects, leaving free cash flow of −$66.0m.
Cash flow statement
| Fiscal year | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMSept 2026 |
|---|---|---|---|---|---|---|---|
| Cash from operations | 522 | 873 | 345 | −17 | 232 | 283 | 554 |
| Depreciation and amortisation | 442 | 415 | 379 | 382 | 436 | 421 | 404 |
| Stock-based pay | 50 | 62 | 62 | 74 | 92 | 149 | 173 |
| Capital spending | 253 | 193 | 175 | 181 | 291 | 349 | 302 |
| Free cash flow | 269 | 680 | 170 | −198 | −59 | −66 | 252 |
| Free cash flow after stock pay | 219 | 618 | 108 | −272 | −151 | −215 | 79 |
| Quarter | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 | 2026 Q3Sept 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | 22 | −25 | 35 | 137 | 136 | 32 | 153 | 233 |
| Depreciation and amortisation | 106 | 106 | 107 | 109 | 99 | 101 | 102 | 102 |
| Stock-based pay | 27 | 28 | 30 | 27 | 64 | 34 | 38 | 37 |
| Capital spending | 92 | 110 | 89 | 74 | 76 | 100 | 71 | 55 |
| Free cash flow | −70 | −135 | −54 | 63 | 60 | −68 | 82 | 178 |
| Free cash flow after stock pay | −97 | −163 | −84 | 36 | −4 | −102 | 44 | 141 |
Compare with peers
- ResMed| cash flow
- Dexcom cash flow
- Steris cash flow
- Idexx Laboratories cash flow
- Edwards Lifesciences cash flow
Head to head: BLCO vs RMDBLCO vs DXCMBLCO vs STEBLCO vs IDXX
More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies